Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment

Inclusion Criteria: 1. Patients diagnosed with urinary system tumors through pathological examination; 2. Meet specific clinical stages and surgical treatment standards; 3. Intraoperative tissue resection meets the sample testing standards; 4. The patient is willing to participate in the study and sign an informed consent form. Exclusion Criteria: 1. Not meeting the specific clinical stage and not receiving surgical treatment; 2. Abnormal mental behavior; 3. Intellectual disability; 4. Age under 18 years old or over 75 years old; 5. Low understanding and communication skills.